National Institutes of Health (NIH) — 2015 Investments
355 investments dated 2015 · page 2 of 2 · listed companies and verified rows first · show all
NĒRx Biosciences is a pre-clinical stage biotechnology company developing targeted anticancer therapeutics focused on the DNA damage response (DDR) and DNA repair.
BiotechHealthtech
NeuroSigma is a bioelectronic medical device company that makes non-invasive external trigeminal-nerve stimulation systems to treat chronic neurological and neuropsychiatric disorders.
Digital HealthHealthtechMedical DevicesLos Angeles, US
Leon Ekchian(Executive Officer, Director)Kirk Calhoun(Director)Lodwrick M. Cook(Director)James Hindman(Director)
Nirvana Sciences develops dyes, probes, and contrast agents for life science applications, including organic dyes with narrow emission profiles and a library of over 700 chlorin and bacteriochlorin designs.
BiotechDeep TechHealthtechNew MaterialsResearch Triangle Park, US
Richard West(Director)Lisa Cooper(Director)Russell Thomas(Executive Officer, Director, Promoter)Wayne Brinster(Director)
PhotoniCare develops OtoSight, an FDA-cleared optical coherence tomography device for non-invasive assessment and monitoring of middle ear infections in healthcare facilities.
Deep TechDigital HealthHealthtechMedical DevicesDurham, US
Ryan Shelton(CEO)Cary Vance(Executive Officer, Director)Gary Durack(Member of the Board of Directors)Stephen Boppart(CMO)
BoardPatrick Zeller(Director)Dale Grogan(Director)
Physical Sciences Inc.
Deep TechDefense TechNew Materials
PlenOptika develops QuickSee Free, a handheld wavefront-based autorefractor and keratometer for measuring vision and eye curvature in clinical, retail, and mobile settings.
HardwareHealthtechMedical DevicesAllston, US
Shivang R. Dave(Executive Officer, Director)
BiotechMilwaukee, US
Daniel Lawton(Executive Officer, Director)Steve Squinto(Director)Tom Beck(Executive Officer, Director)Patrick Schwarz-Schuette(Director)Chad Beyer(Executive Officer)
BoardKlaus Veitinger(Executive Officer, Director)
ProThera Biologics develops therapies based on Inter-alpha inhibitor proteins (IAIP), a class of human plasma proteins with anti-inflammatory activity, to treat patients with severe inflammatory diseases.
BiotechHealthtechProvidence, US
Denice Spero(Executive Officer)Richard G. Horan(Director)Richard A. Andrews(Director)Yow-Pin Lim(Executive Officer, Director)Douglas C. Hixson(Director)
Recombinetics develops gene-edited animals, offering custom gene-edited swine models for translational preclinical and biomedical research, including reporter and cancer models.
AgTechBiotechSt. Paul, US
Mark Kroll, Ph.D.(Director)John Cameron(Executive Officer)David Aberle(Executive Officer)Peter Hajas(Director)Scott C. Fahrenkrug, Ph.D.(Director, Promoter)Justin Zenanko(Executive Officer)
Renova Therapeutics develops investigational gene therapies intended as single-dose, long-lasting treatments for common chronic diseases, with an initial focus on congestive heart failure and type 2 diabetes.
BiotechHealthtechCarlsbad, US
Roy Cosan(Director)Pierre Lecocq(Director)Vijay Mahant(Director)Michael Torres(Director)Kirk Hammond(Director)William Davidson(Director)
The page is a Thai-language online lottery betting platform offering wagers on Thai, Lao, and Hanoi lottery draws with automated deposit/withdrawal and real-time results.
Consumer
Ribonova is a biopharmaceutical company discovering and developing novel small-molecule medicines for patients with serious rare diseases.
BiotechMedical Devices
HealthtechCambridge, US
Adam Rosenberg(Executive Officer, Director)Bruce Booth(Director)Kees Been(Director)Samantha Singer(Director)
Scene Health offers a medication adherence platform ("MedEngagement") that combines a multilingual app, asynchronous video Directly Observed Therapy (DOT), and a care team to help patients take medications properly and improve clinical outcomes.
Digital HealthHealthtechSaaS
HealthtechSan Jose, US
Thom Rasche(Director)Thomas Thaler(Director)Michael Henson(Executive Officer, Director)Edward F. Ruppel, Jr(Executive Officer, Director)Carolyn M. Bruguera(Executive Officer)Duncan Maitland(Director)
Silver Creek is a clinical-stage biopharmaceutical company developing targeted growth factor fusion protein therapies based on its Smart Growth Factor technology to treat damaged tissues.
BiotechHealthtechSan Francisco, US
James Marks(Director)Ross Breckenridge(Executive Officer, Director)Michael Fairbanks(Director)Ulrik Nielsen(Director)Tom Murtagh(Director)Birgit Schoeberl(Executive Officer, Director)
Sinopia Bio is a biotechnology company developing a therapeutic pipeline focused on Parkinson's disease.
BiotechSan Diego, US
Aarash Bordbar(Executive Officer, Director)Arthur T Suckow(Director)Bernhard Palsson(Director)Iman Famili(Director)
HealthtechCleveland, US
Josh Boggs(Executive Officer)Mark Stulz(Executive Officer)Marilyn A. Eisele(Executive Officer)Les C. Vinney(Director)Maria E. Bennett(Executive Officer, Director)
BoardGeoffrey B. Thrope(Director)
Stemina Biomarker Discovery develops human cell-based in vitro toxicity assays—using metabolomics and induced pluripotent stem cells—to predict developmental toxicity and cardiotoxicity of drug candidates, chemicals, cosmetics, and tobacco ingredients as an alternative to animal testing.
BiotechDigital HealthHealthtechMadison, US
Andrew Ferrara(Director)R. Andrew Morgan(Director)Scott Carr(Director)Kevin Krenitsky(Director)Elizabeth L.R. Donley(Executive Officer, Director)Robert E. Burrier(Executive Officer)
Synedgen develops first-in-class glycomics-based regenerative therapeutics that repair mucosal injury and restore barrier function.
BiotechHealthtechClaremont, US
Shenda Baker(Executive Officer, Director)William P. Wiesmann(Executive Officer, Director)Kaveri Parker(Executive Officer)Clarke Atwell(Director)Larry Shapiro(Director)Diane Olmstead(Director)
Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.
Digital HealthHealthtechMedical DevicesSeattle, US
Ben Casavant(Co-Founder and Chief Executive Officer)Erwin Berthier(Co-Founder and Chief Technology Officer)Alan Levy(Director)
BoardElizabeth Hambrecht(Director)Paul Conley(Director)
Terrestrial develops the Tacterra microarray patch platform, a dissolvable skin-patch technology for delivering therapies including GLP-1 without injection.
BiotechHealthtechMedical Devices
Rachel Sha(CEO)
HealthtechWest Lafayette, US
Pu Wang(Executive Officer, Promoter)Ji-Xin Cheng(Executive Officer, Director, Promoter)
Widetronix designs and manufactures ultra-low power sensor platforms powered by betavoltaic energy sources, with operational lifetimes designed to exceed 25 years.
Deep TechHardwareSemiconductorsIthaca, US
Jonathan Greene(Executive Officer, Director)Christopher Thomas(Executive Officer, Director)Lucas Nelson(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.